检索结果 - Neal I. Lindeman

Refine Results
  1. 1
    The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice

    The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice 由 Frank C. Kuo, Brenton G. Mar, R. Coleman Lindsley, Neal I. Lindeman

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes

    Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes 由 Gabriel K. Griffin, Lynette M. Sholl, Neal I. Lindeman, Christopher D.�M. Fletcher, Jason L. Hornick

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    HPV-16 in a distinct subset of oral epithelial dysplasia

    HPV-16 in a distinct subset of oral epithelial dysplasia 由 Mark A. Lerman, Soulafa Almazrooa, Neal I. Lindeman, D. Greg Hall, Alessandro Villa, Sook‐Bin Woo

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    <i>EGFR</i> mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

    <i>EGFR</i> mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer 由 Jason H. Smouse, Edmund S. Cibas, Pasi A. Jänne, Victoria A. Joshi, Kelly H. Zou, Neal I. Lindeman

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma

    Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma 由 Elizabeth H. Stover, Colleen M. Feltmate, Ross S. Berkowitz, Neal I. Lindeman, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior

    Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior 由 Anjelica Hodgson, Brooke E. Howitt, Kay J. Park, Neal I. Lindeman, Marisa R. Nucci, Carlos Parra‐Herran

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies

    Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies 由 Michael Kluk, R. Coleman Lindsley, Jon C. Aster, Neal I. Lindeman, David Szeto, Dimity Hall, Frank C. Kuo

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas

    Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas 由 Natasha Novikov, Gabriel K. Griffin, Graham Dudley, Mai Drew, Vanesa Rojas‐Rudilla, Neal I. Lindeman, David M. Dorfman

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Predicting the origin of mutations from tumour and germline data

    Predicting the origin of mutations from tumour and germline data 由 Israel Bio, Samantha Stokes, Alexander Gusev, Bruce E. Johnson, Neal I. Lindeman, Laura E. MacConaill, Shridar Ganesan

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Worldwide Frequency of Commonly Detected EGFR Mutations

    Worldwide Frequency of Commonly Detected EGFR Mutations 由 Rondell P. Graham, Amanda L. Treece, Neal I. Lindeman, Patricia Vasalos, Mu Shan, Lawrence J. Jennings, David L. Rimm

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    The Role of MGMT Testing in Clinical Practice

    The Role of MGMT Testing in Clinical Practice 由 Milena Cankovic, Marina N. Nikiforova, Matija Snuderl, Adekunle M. Adesina, Neal I. Lindeman, Patrick Y. Wen, Eudocia Q. Lee

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  12. 12
    Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas

    Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas 由 Lynette M. Sholl, Stanislawa Weremowicz, Stacy W. Gray, Kwok‐Kin Wong, Lucian R. Chirieac, Neal I. Lindeman, Jason L. Hornick

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells

    Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells 由 Natsumi Irahara, Katsuhiko Nosho, Yoshifumi Baba, Kaori Shima, Neal I. Lindeman, Aditi Hazra, Eva Schernhammer, David J. Hunter, Charles S. Fuchs, Shuji Ogino

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas

    Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas 由 Melanie Johncilla, Matthew D. Stachler, Joseph Misdraji, Mikhail Lisovsky, Masato Yozu, Neal I. Lindeman, Gregory Y. Lauwers, Robert D. Odze, Amitabh Srivastava

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma

    SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma 由 David L. Kolin, Fei Dong, Michele Baltay, Neal I. Lindeman, Laura E. MacConaill, Marisa R. Nucci, Christopher P. Crum, Brooke E. Howitt

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung

    Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung 由 Andrew M. Brunner, Daniel B. Costa, Rebecca S. Heist, Elizabeth Garcia, Neal I. Lindeman, Lynette M. Sholl, Geoffrey R. Oxnard, Bruce E. Johnson, Peter S. Hammerman

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions

    Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions 由 Geoffrey R. Oxnard, Peter Lo, Mizuki Nishino, Suzanne E. Dahlberg, Neal I. Lindeman, Mohit Butaney, David M. Jackman, Bruce E. Johnson, Pasi A. Jänne

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <i>EGFR</i> Wild-type Cancers

    Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <i>EGFR</i> Wild-type Cancers 由 Kimio Yonesaka, Kreshnik Zejnullahu, Neal I. Lindeman, Alison J. Homes, David M. Jackman, Feng Zhao, Andrew M. Rogers, Bruce E. Johnson, Pasi A. Jänne

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma

    Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma 由 David Papke, Jonathan A. Nowak, Matthew B. Yurgelun, Alexander Frieden, Amitabh Srivastava, Neal I. Lindeman, Lynette M. Sholl, Laura E. MacConaill, Fei Dong

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    <i>EGFR</i>Mutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry

    <i>EGFR</i>Mutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry 由 Lynette M. Sholl, Yun Xiao, Victoria A. Joshi, Beow Y. Yeap, Leigh‐Anne Cioffredi, David M. Jackman, Charles Lee, Pasi A. Jänne, Neal I. Lindeman

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: